Dark

Check out our Level2View

EYEG
AB Corporate Bond ETF
stock NASDAQ

At Close

Jul 30, 2025

0.00USD0.000%(0.00)12

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD0.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Nov 8, 2021

07:30AM EST EyeGate is Now Kiora Pharmaceuticals; Provides Update on GlobeNewswire Inc

Oct 26, 2021

07:00AM EDT EyeGate Pharmaceuticals Appoints Eric J. Daniels, MD, MBA, as GlobeNewswire Inc

Sep 30, 2021

03:41PM EDT Eyegate Pharmaceuticals Files For Patent Application Titled 'COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASE BY CONTACT LENS MEDIATED DRUG DELIVERY' Benzinga

10:21AM EDT EYEG: Refreshed and moving forward Benzinga

Sep 23, 2021

10:06AM EDT EyeGate Pharma US Patent & Trademark Office Abstract For Co.'s 'Compositions and Methods for Treatment of Ocular Conditions' Benzinga

Sep 9, 2021

04:15PM EDT EyeGate to Present at the H.C. Wainwright 23rd Annual Global GlobeNewswire Inc

Sep 8, 2021

06:56AM EDT EyeGate Pharma Completes Target Enrollment In Phase 2 Proof-Of-Concept Study To Evaluate PP-001 For The Treatment Of Ocular Surface Inflammation Benzinga

06:55AM EDT -Proof-of-concept study conducted in Austria; Study designed to build upon positive Phase 1 safety data in healthy volunteers- GlobeNewswire Inc

Sep 1, 2021

06:07AM EDT The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 5.45 A.M. EDT). RTTNews

Aug 19, 2021

10:57AM EDT The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck Benzinga

Aug 17, 2021

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

Aug 16, 2021

10:20AM EDT HC Wainwright & Co. Maintains Buy on Eyegate Pharmaceuticals, Lowers Price Target to $11 Benzinga

Aug 13, 2021

07:43AM EDT The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO Benzinga

Aug 12, 2021

08:09AM EDT The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma Benzinga

Aug 11, 2021

04:15PM EDT EyeGate Announces Closing of $10.75 Million Registered Direct GlobeNewswire Inc

08:14AM EDT The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering Benzinga

Aug 10, 2021

02:31PM EDT Mid-Afternoon Market Update: 3D Systems Surges On Upbeat Earnings; Katapult Shares Drop Benzinga

12:09PM EDT Mid-Day Market Update: Crude Oil Rises Over 3%; comScore Shares Plummet Benzinga

07:55AM EDT The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts Benzinga

06:58AM EDT EyeGate Announces $10.75M Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Benzinga

06:55AM EDT EyeGate Announces $10.75 Million Registered Direct Offering Priced GlobeNewswire Inc

Aug 6, 2021

07:42AM EDT The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO Benzinga

Aug 5, 2021

08:08AM EDT The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO Benzinga

Aug 3, 2021

07:55AM EDT The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business Benzinga

Jul 30, 2021

07:54AM EDT The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs Benzinga

Jul 27, 2021

11:13AM EDT The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts Benzinga

Jul 26, 2021

04:21PM EDT EyeGate Announced It Has Entered A Non-Binding Letter Of Intent To Acquire Bayon Therapeutics For Approximately $7.1M Or Up To 2.2M Shares Of The Company's Common Stock Or Common Stock Equivalents Benzinga

04:16PM EDT EyeGate Pharmaceuticals Announced It Has Appointed Brian M. Strem As President And CEO Benzinga

04:15PM EDT EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, GlobeNewswire Inc

Jun 14, 2021

03:33PM EDT EyeGate shares were trading higher after the company announced the first patient has been dosed for PP-001 in a Phase 2 proof-of-concept Ocular Surface Inflammation Study. Benzinga

06:56AM EDT EyeGate Pharma Announces First Patient Dosed for PP-001 in a Phase 2 Proof-of-Concept Ocular Surface Inflammation Study Benzinga

06:55AM EDT - Proof-of-concept study conducted in Austria--Topline data expected in Q4 2021- GlobeNewswire Inc

May 23, 2021

06:21AM EDT EYEG: Maturing and evolving Benzinga

May 12, 2021

04:41PM EDT EyeGate Pharma Reports Q1 Cash And Cash Equivalents $6.61M Compared To $1.186M YoY Benzinga

04:15PM EDT - PP-001: proof-of-concept study in Austria for dry eye patients expected to initiate in Q3:21; U.S. IND submission planned in Q4:21- GlobeNewswire Inc

Apr 1, 2021

07:15AM EDT EyeGate Pharma Appoints Kenneth Gayron And Aron Shapiro To Its Board Of Directors Benzinga

06:55AM EDT EyeGate Pharma Announces the Appointment of Kenneth Gayron and GlobeNewswire Inc

Mar 25, 2021

04:18PM EDT EyeGate Pharma FY 2020 Revs $12K Vs $30k Est Benzinga

04:15PM EDT EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (EyeGate or the Company), a clinical-stage company developing and commercializing products for treating inflammatory and immune diseases with a focus on the eye and nervous system, today announced financial results for the year ended December 31, 2020 and provided an update on recent corporate and operational activities. GlobeNewswire Inc

Feb 1, 2021

06:56AM EST EyeGate Pharmaceuticals Announces Management Transition; Franz Obermayr Appointed Acting CEO Benzinga

06:55AM EST - Franz Obermayr, Ph.D. Appointed as Acting Chief Executive Officer, Transitioning From EVP Clinical Development - GlobeNewswire Inc

Jan 6, 2021

07:31AM EST The Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping Benzinga

06:56AM EST EyeGate Enters Into Agreement For $8M Private Placement Benzinga

06:55AM EST EyeGate Enters Into Agreement for $8.0 Million Private Placement GlobeNewswire Inc

Jan 4, 2021

08:21AM EST EYEG: Expanding the pipeline Benzinga

Dec 21, 2020

02:51PM EST Mid-Afternoon Market Update: Dow Turns Positive; uniQure Shares Slide Benzinga

12:13PM EST Mid-Day Market Update: Crude Oil Down 4%; 500.com Shares Spike Higher Benzinga

10:22AM EST Mid-Morning Market Update: Markets Open Lower; FactSet Research Beats Q1 Estimates Benzinga

10:15AM EST Stock Alert: EyeGate Pharmaceuticals Soars Above 75% RTTNews

10:10AM EST Biopharma M&A Continues: Agios Sells Oncology Portfolio, NantKwest's Reverse Merger With ImmunityBio, Eyegate Picks Up Panoptes Benzinga

08:13AM EST Benzinga Pro's Top 5 Stocks To Watch For Monday, Dec. 21, 2020: EYEG, NKE, ZM, WMT, AIM Benzinga

06:56AM EST EyeGate Pharma Announces Acquisition of Panoptes Pharma For $4M At Close Consisting Of EyeGate Common Stock Benzinga

06:55AM EST Expands Pipeline Beyond Ophthalmology with PP-001, a Clinical Stage, Best-in-Class DHODH Inhibitor GlobeNewswire Inc

Nov 12, 2020

07:44AM EST The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal Benzinga

06:27AM EST HC Wainwright & Co. Maintains Buy on Eyegate Pharmaceuticals, Lowers Price Target to $10 Benzinga

Nov 11, 2020

07:38AM EST The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap Benzinga

Nov 6, 2020

02:45PM EST Stocks Trading Near 52-Week Lows On Friday, Nov. 6, 2020: ASRT, KBLMU, PNRG, YGMZ, APRE, UHT, LAIX, CLI, CORR, ANIP, CCOI, KBLM, NYC, UTL, PEI, TIG, EYEG, PVL, ZSAN, TTNP, NBRV, SFT, WPG, IFS, COGT, LMNL, PRFX, GBT, FNHC, ASMB, EPZM, UCL Benzinga

07:47AM EST The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold Benzinga

Aug 12, 2020

12:00PM EDT Mid-Day Market Update: Nasdaq Rises 2%; Cellular Biomedicine Shares Spike Higher Benzinga

10:20AM EDT Mid-Morning Market Update: Markets Open Higher; Brinker Reports Mixed Q4 Results Benzinga

06:59AM EDT EyeGate Pharma Confirms Path Forward With FDA To Develop MoxiGel Combination Product; Says Has Received Positive Feedback Following Pre-IND Meeting Benzinga

Jul 21, 2020

09:37AM EDT Benzinga's Top Upgrades, Downgrades For July 21, 2020 Benzinga

07:42AM EDT Alliance Global Partners Initiates Coverage On Eyegate Pharmaceuticals with Buy Rating, Announces Price Target of $9.5 Benzinga

Jul 14, 2020

06:56AM EDT EyeGate Pharma To Proceed With PE Pivotal Study Benzinga

Share